LINC01714 and cholangiocarcinoma: In cholangiocarcinoma (CCA), LINC01714 was shown to be recurrently down-regulated in clinical samples and significantly correlated with overall survival in patients, and overexpression of LINC01714 inhibited the proliferation, migration and invasion of cancer cells both in vitro and in vivo285.